Cita APA

Cannizzo, B., Quesada, I. M., Militello, R. D., Amaya, C., Miatello, R. M., Cruzado, M., & Castro, C. M. (2014). Tempol attenuates atherosclerosis associated with metabolic syndrome via decreased vascular inflammation and NADPH-2 oxidase expression. Web

Citación estilo Chicago

Cannizzo, Beatriz, Isabel María Quesada, Rodrigo Damián Militello, Celina Amaya, Roberto Miguel Miatello, M. Cruzado, and Claudia Magdalena Castro. Tempol Attenuates Atherosclerosis Associated With Metabolic Syndrome Via Decreased Vascular Inflammation and NADPH-2 Oxidase Expression. 2014.

Cita MLA

Cannizzo, Beatriz, et al. Tempol Attenuates Atherosclerosis Associated With Metabolic Syndrome Via Decreased Vascular Inflammation and NADPH-2 Oxidase Expression. 2014.